Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)

Autor:	F. Carpagnano, A. Le Groumellec, Tomasz Grodzki, Rodryg Ramlau, J. Gasmi, J. Gonzalez-Larriba, M. De Lena, Rafael Rosell, J.-Y. Douillard, D. Aubert
Rok vydání:	2005
Předmět:	Pulmonary and Respiratory Medicine Oncology Cisplatin Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment non-small cell lung cancer (NSCLC) Vinorelbine medicine.disease Internal medicine medicine business Adjuvant medicine.drug
Zdroj:	Lung Cancer. 49:S3-S4
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(05)80129-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::233f26c8af8639811da8a340b3d56d13 https://doi.org/10.1016/s0169-5002(05)80129-1 Zobrazit plný text záznamu Full Text from ScienceDirect